← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Helixbind, Inc.
Boxborough, MA
$43,151,128
Total funding
18
Grants
Funding over time
peak $8M · FY2013–25$10M$7.5M$5M$2.5M$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$42,971,128 · 17
NSF$180,000 · 1
By mechanism
R44$33,971,955 · 10
SB1$7,997,234 · 3
R43$1,001,939 · 4
—$180,000 · 1
Investigators at Helixbind, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Direct detection and identification of antimicrobial resistance genes in bloodstream infections$1,050,000
R44 · FY2022 · AI
Diagnostic tool for assessment and tracking of microbial load in bloodstream infections$1,050,000
R44 · FY2023 · AI
Direct-from-specimen identification of pathogens common in endocarditis$1,049,999
R44 · FY2025 · AI
An automated culture-free system for the identification of bloodstream infections direct from blood$1,027,841
R44 · FY2025 · AI
A sample-to-answer diagnostic for neonatal bloodstream infections$1,003,051
R44 · FY2017 · HD
Direct-from-specimen identification of pathogens common in endocarditis$1,001,029
R44 · FY2024 · AI
Commercialization Readiness Pilot (CRP) program support for: An Integrated Device for identification of bloodstream infections directly from blood$1,000,000
SB1 · FY2024 · AI
Direct detection and identification of antimicrobial resistance genes in bloodstream infections$1,000,000
R44 · FY2023 · AI
An Integrated Device for Rapid Bacteremia Diagnosis Direct from Whole Blood$1,000,000
R44 · FY2021 · AI
Commercialization Readiness Pilot (CRP) program support for: Direct-from-specimen identification of pathogens common in endocarditis$1,000,000
SB1 · FY2023 · AI
Direct detection and identification of antimicrobial resistance genes in bloodstream infections$1,000,000
R44 · FY2024 · AI
An automated platform for direct-from-specimen identification of pathogens common in endocarditis$1,000,000
R44 · FY2021 · AI
An automated culture-free system for the identification of bloodstream infections direct from blood$1,000,000
R44 · FY2024 · AI
A Culture-Free Platform for Rapid Fungal Pathogen Identification$1,000,000
R44 · FY2021 · AI
Commercialization Readiness Pilot (CRP) program support for: Ultra-sensitive, direct-from-blood, molecular detection of Borrelia infections.$1,000,000
SB1 · FY2025 · AI
Massively Multiplexed dsDNA Invasion Arrays$1,000,000
R44 · FY2021 · AI
An Integrated Device for Rapid Bacteremia Diagnosis Direct from Whole Blood$1,000,000
R44 · FY2022 · AI
Commercialization Readiness Pilot (CRP) program support for: An Integrated Device for identification of bloodstream infections directly from blood$1,000,000
SB1 · FY2022 · AI
A Culture-Free Platform for Rapid Fungal Pathogen Identification$1,000,000
R44 · FY2022 · AI
Commercialization Readiness Pilot (CRP) program support for: An Integrated Device for identification of bloodstream infections directly from blood$1,000,000
SB1 · FY2023 · AI